New Epilepsy Drug Created By 3D Printing May Provide Relief from Seizures

Posted on March 25, 2016 by Disability Help Group

Anti-seizure medications have come a long way in the past several decades, giving a new lease on life to many people living with epilepsy. One of the complications of oral epilepsy medications is safely administering the drug without fear of choking when the person is having a seizure. The breakthroughs in 3D printing technology may have found a permanent solution.

The pharmaceutical company Aprecia, has just obtained approval from the U.S. Food and Drug Administration (FDA) for its new epilepsy medication, SPRITAM. Using 3D printing technology, researchers developed the oral tablet to dissolve rapidly with water, reducing the risk of choking. SPRITAM is the first prescription drug created by 3D printing to obtain approval from the FDA.

Researchers created SPRITAM with ZipDose Technology, Apreca’s proprietary 3D printing method that allows for precision manufacturing of rapidly disintegrating medications. According to Aprecia, patients can use SPRITAM for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures.

Researchers may able to apply this new development method to medications for patients with swallowing disorders or young children unfamiliar with taking pills.

Epilepsy is a health condition that nearly three million people lived with on a daily basis in 2013. Every year, doctors diagnose approximately 150,000 new cases, many at birth. While living a normal life with epilepsy is possible, it can make everyday tasks like driving or working extremely difficult or even impossible.

Disability Benefits May Be Available to People With Epilepsy

If your epilepsy hinders you from working and earning a substantial income, you may qualify for Social Security disability benefits.

Contact the Disability Help Group at 800-800-2009 to schedule a consultation with our disability advocates today. We can help you get the benefits you need and deserve.